Literature DB >> 14007068

[A contribution to the clinical aspects of malignant chorio-epithelioma with special reference to lutein cyst formation].

I WILL.   

Abstract

Entities:  

Keywords:  CHORIOCARCINOMA/pathology; GONADOTROPINS/physiology; OVARY/pathology

Mesh:

Substances:

Year:  1962        PMID: 14007068     DOI: 10.1007/BF02590007

Source DB:  PubMed          Journal:  Arch Gynakol        ISSN: 0003-9128


× No keyword cloud information.
  15 in total

1.  [Chorioepithelioma in late pregnancy].

Authors:  H J SIEGELER; G FRANZ
Journal:  Geburtshilfe Frauenheilkd       Date:  1959-01       Impact factor: 2.915

2.  [Acute complications of massive ovarian luteinization. Posology of the gonadotropins in gynecology].

Authors:  C BECLERE
Journal:  Presse Med       Date:  1960-01-09       Impact factor: 1.228

3.  [Pathology of trophoblast development; chorioepithelioma malignum and chorioepitheliosis].

Authors:  E KEHRER
Journal:  Z Geburtshilfe Gynakol       Date:  1956

4.  Some observations on the histology of the human ovary during pregnancy.

Authors:  W W NELSON; R R GREENE
Journal:  Am J Obstet Gynecol       Date:  1958-07       Impact factor: 8.661

5.  Choriocarcinoma of the fallopian tube coincident with viable pregnancy.

Authors:  W E CRISP
Journal:  Am J Obstet Gynecol       Date:  1956-02       Impact factor: 8.661

6.  [Ovarian tumor and pregnancy].

Authors:  E LEWIN
Journal:  Zentralbl Gynakol       Date:  1954

7.  [Contribution to ectopic malignant chorion epithelioma].

Authors:  K GUSENLEITNER
Journal:  Wien Med Wochenschr       Date:  1954-06-26

8.  [Investigations on hormonal and pathophysiologic modifications in hydatiform mole].

Authors:  L LAJOS; F E SZONTAGH
Journal:  Zentralbl Gynakol       Date:  1950

9.  [Spontaneous rupture of the uterus in chorionic epithelioma].

Authors:  R CORDUA
Journal:  Zentralbl Gynakol       Date:  1950

10.  Pathological aspects of hydatidiform mole and choriocarcinoma.

Authors:  E NOVAK
Journal:  Am J Obstet Gynecol       Date:  1950-06       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.